SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,682 | -98.3% | 61 | -98.1% | 0.00% | -98.6% |
| Q2 2023 | $97,605 | -35.6% | 3,247 | -22.4% | 0.07% | -38.3% |
| Q1 2023 | $151,514 | +61.2% | 4,182 | +43.1% | 0.12% | +85.5% |
| Q1 2022 | $94,000 | +118.6% | 2,922 | +97.8% | 0.06% | +138.5% |
| Q4 2021 | $43,000 | -78.7% | 1,477 | -80.9% | 0.03% | -82.4% |
| Q1 2021 | $202,000 | +6633.3% | 7,725 | +7625.0% | 0.15% | +7300.0% |
| Q4 2020 | $3,000 | -95.4% | 100 | -96.4% | 0.00% | -96.6% |
| Q2 2020 | $65,000 | +12.1% | 2,740 | +182.5% | 0.06% | +9.3% |
| Q2 2018 | $58,000 | – | 970 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |